Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
    • COVID-19 Content and Resources
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Other Publications
    • ajnr

User menu

  • Subscribe
  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

  • Subscribe
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
    • COVID-19 Content and Resources
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds
ReplyLETTER

Reply:

F. Bala, J. Siddiqui, S. Sciacca, A.M. Falzon, M. Benger, S.A. Matloob, F.N.A.C. Miller, R.J. Simister, I. Chatterjee, L.K. Sztriha, I. Davagnanam and T.C. Booth
American Journal of Neuroradiology August 2021, 42 (8) E54-E55; DOI: https://doi.org/10.3174/ajnr.A7161
F. Bala
aDepartment of NeuroradiologyKing's College Hospital, National Health Service Foundation TrustLondon, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for F. Bala
J. Siddiqui
aDepartment of NeuroradiologyKing's College Hospital, National Health Service Foundation TrustLondon, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J. Siddiqui
S. Sciacca
bLysholm Department of Neuroradiology National Hospital for Neurology and NeurosurgeryUniversity College London Hospitals, National Health Service Foundation TrustLondon, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S. Sciacca
A.M. Falzon
bLysholm Department of Neuroradiology National Hospital for Neurology and NeurosurgeryUniversity College London Hospitals, National Health Service Foundation TrustLondon, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A.M. Falzon
M. Benger
cDepartment of NeurologyKing's College Hospital, National Health Service Foundation TrustLondon, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M. Benger
S.A. Matloob
dDepartment of Neurosurgery National Hospital for Neurology and NeurosurgeryUniversity College London Hospitals, National Health Service Foundation TrustLondon, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S.A. Matloob
F.N.A.C. Miller
eDepartment of RadiologyKing's College Hospital National Health Service Foundation TrustLondon, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for F.N.A.C. Miller
R.J. Simister
fComprehensive Stroke ServiceUniversity College London Hospitals, National Health Service Foundation Trust, Stroke Research Centre, University College London Queen Square Institute of NeurologyLondon, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for R.J. Simister
I. Chatterjee
gComprehensive Stroke ServiceUniversity College London Hospitals, National Health Service Foundation TrustLondon, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for I. Chatterjee
L.K. Sztriha
hDepartment of NeurologyKing's College Hospital National Health Service Foundation TrustLondon, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for L.K. Sztriha
I. Davagnanam
iLysholm Department of Neuroradiology National Hospital for Neurology and NeurosurgeryUniversity College London Hospitals, National Health Service Foundation TrustLondon, United KingdomBrain Repair & Rehabilitation Unit University College London Queen Square Institute of NeurologyLondon, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for I. Davagnanam
T.C. Booth
jDepartment of NeuroradiologyKing's College Hospital, National Health Service Foundation TrustLondon, United KingdomSchool of Biomedical Engineering and Imaging SciencesKing's College LondonLondon, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for T.C. Booth
  • Article
  • Info & Metrics
  • References
  • PDF
Loading

We thank Marquez et al for their interest in our study.1 Their points are worthy of a discussion. Our article demonstrates a highly sensitive and specific biomarker, namely apical ground-glass opacification (GGO) seen on carotid CTA, in a cohort of patients with suspected stroke during the pandemic (sensitivity, 75% [95% CI, 56–87]; specificity, 81% [95% CI, 71–88]; OR = 11.65 [95% CI, 4.14–32.78]; P = .001). The sample was accrued continuously from March through April 2020 from a population scanned for the indication of suspected acute stroke, not for suspected coronavirus disease 2019 (COVID-19). This study simply highlights the importance of vigilance in assessment of the lung apices when reporting carotid CTAs in the population with suspected acute stroke. Most patients in our study were without typical symptoms of COVID-19. We used other information readily available at the time of the carotid CTA acquisition but were unable to find any other additional biomarkers. This included demographics, clinical history, symptoms and signs, as well as chest radiographs2 (which are typically obtained shortly after the admission of patients with acute stroke). In summary, we recommend routinely analyzing lung apices in patients with stroke undergoing carotid CTA, because this rapid and easy assessment of apices is valuable, opportunistic, and “free” information in a routine and unmodified scan. The apical analysis simply identifies patients likely to have COVID-19 with early downstream benefits such as limiting disease transmission.

We reiterate that reverse transcriptase polymerase chain reaction (RT-PCR) should not be omitted or replaced. Such patients still require formal RT-PCR testing according to hospital policy. In some hospitals, RT-PCR testing may be required for all emergency admissions; in others, it may be just for those patients who have clinical features suggestive of COVID-19. Regardless of RT-PCR indication, we again point out that RT-PCR takes hours to process. In the interim, the opportunistic and free information we describe in analyzing the lung apices is of benefit. In our hospitals, apical analysis is now articulated in reports to good effect, for example, changing staff personal protective equipment requirements (eg, from a fluid-repellant surgical mask to an FFP3 or N95 mask), and directing a patient to a side room instead of an open ward, pending RT-PCR results.

We agree that chest CT findings of COVID-19 are useful when found; however, we highlight that guidance from both the Royal College of Radiologists (UK) and the American College of Radiology do not recommend routine chest CT scanning as a means of diagnosing Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2).3,4

It remains challenging to draw definitive conclusions from any index test (apical GGO analysis) compared with a reference standard (RT-PCR), which itself is not of optimal sensitivity.5 However, our study showed that apical GGO alone is a prognostic biomarker of 30-day mortality. In other words, regardless of whether RT-PCR had been performed, and regardless of the RT-PCR result if performed, the absence of apical GGO confers a survival advantage compared with those with the presence of apical GGO (5.7% versus 18.0% mortality, P = .017; hazard ratio = 3.51 [95% CI, 1.42–8.66]; P = .006). This would further support the use of an opportunistic and free biomarker in a routine scan as being valuable.

We concur and mention in our article that the inferior and posterior pulmonary segments are more often affected in SARS-CoV-2 infection; however, we do not recommend routinely scanning the entire lungs with chest CT, without clinical indication, in keeping with the published guidance mentioned above.

Regarding the suggestion to include comorbidities and risk factors for stroke, we refer the authors to Online Table 4. Here it shows that key stroke risk factors were included in our study (hypertension, diabetes mellitus, atrial fibrillation, hyperlipidemia, history of stroke/TIA, and smoking status) and were incorporated as covariates in the bivariate and multivariate analyses.

Our primary objective was to determine candidate diagnostic biomarkers for COVID-19, but we agree there were some interesting additional findings from our study regarding the association between SARS-CoV-2 infection and stroke. For example, a contributory mechanism to COVID-19-related excess mortality might be thromboembolic because increased carotid occlusion was associated with GGO (16.0% versus 3.4%, P = .004; OR = 6.82 [95% CI, 1.97–23.53]; P = .002), and our multivariate analysis suggested carotid occlusion was likely to be an independent predictor of death.

While this study was based in London, United Kingdom, and included 3 hospitals with a nonwhite population ranging from 10% to 40%, with patients from a variety of socioeconomic status in the catchment area, we believe the biomarker would benefit from further rigorous temporal and spatial validation. In other words, having developed the biomarker, we should now test it on a cohort of patients from hospitals throughout an entire nation with prospective data collection at a subsequent time point in the pandemic. Such a study to obtain highly representative samples of the populations with acute stroke during the COVID-19 pandemic is currently underway.6

Footnotes

  • This work was supported by the Wellcome/Engineering and Physical Sciences Research Council Center for Medical Engineering (WT 203148/Z/16/Z).

References

  1. 1.↵
    1. Siddiqui J,
    2. Bala F,
    3. Sciacca S, et al
    . COVID-19 stroke apical lung examination study: a diagnostic and prognostic imaging biomarker in suspected acute stroke. AJNR Am J Neuroradiol 2021;42:138–43 doi:10.3174/ajnr.A6832 pmid:32943416
    Abstract/FREE Full Text
  2. 2.↵
    1. Siddiqui J,
    2. Bala F,
    3. Sciacca S, et al
    . A comparison of chest radiograph and CTA apical pulmonary findings in patients presenting with suspected acute stroke during the COVID-19 pandemic. AJNR Am J Neuroradiol 2021;42:E13–14 doi:10.3174/ajnr.A6940 pmid:33272951
    FREE Full Text
  3. 3.↵
    American College of Radiology (ACR). ACR Recommendations for the Use of Chest Radiography and Computed Tomography (CT) for Suspected COVID-19 Infection. https://www.acr.org/Advocacy-and-Economics/ACR-Position-Statements/Recommendations-for-Chest-Radiography-and-CT-for-Suspected-COVID19-Infection Accessed March 25, 2021.
  4. 4.↵
    The Royal College of Radiologists. The role of CT in patients suspected with COVID-19 infection. https://www.rcr.ac.uk/college/coronavirus-covid-19-what-rcr-doing/clinical-information/role-ct-chest/role-ct-patients Accessed March 25, 2021.
  5. 5.↵
    1. Jarrom D,
    2. Elston L,
    3. Washington J, et al
    . Effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis: a rapid systematic review. BMJ Evidence-Based Medicine 2020 Oct 1. [Epub ahead of print] doi:10.1136/bmjebm-2020-111511 pmid:33004426
    Abstract/FREE Full Text
  6. 6.↵
    King's College Hospital National Health Service Trust. COVID-19 Stroke Apical Lung Examination Study - A Multi-Centre Prospective Study. ClinicalTrials.gov; 2021. https://clinicaltrials.gov/ct2/show/NCT04640428 Accessed March 24, 2021.
  • © 2021 by American Journal of Neuroradiology
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 42 (8)
American Journal of Neuroradiology
Vol. 42, Issue 8
1 Aug 2021
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Reply:
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Reply:
F. Bala, J. Siddiqui, S. Sciacca, A.M. Falzon, M. Benger, S.A. Matloob, F.N.A.C. Miller, R.J. Simister, I. Chatterjee, L.K. Sztriha, I. Davagnanam, T.C. Booth
American Journal of Neuroradiology Aug 2021, 42 (8) E54-E55; DOI: 10.3174/ajnr.A7161

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Reply:
F. Bala, J. Siddiqui, S. Sciacca, A.M. Falzon, M. Benger, S.A. Matloob, F.N.A.C. Miller, R.J. Simister, I. Chatterjee, L.K. Sztriha, I. Davagnanam, T.C. Booth
American Journal of Neuroradiology Aug 2021, 42 (8) E54-E55; DOI: 10.3174/ajnr.A7161
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Footnotes
    • References
  • Info & Metrics
  • References
  • PDF

Related Articles

  • COVID-19 Stroke Apical Lung Exam Study: Is it Really an Accurate Diagnostic Method?
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Fair Performance of CT in Diagnosing Unilateral Vocal Fold Paralysis
  • Reply:
  • Regarding “Altered Blood Flow in the Ophthalmic and Internal Carotid Arteries in Patients with Age-Related Macular Degeneration Measured Using Noncontrast MR Angiography at 7T”
Show more LETTERS

Similar Articles

Advertisement

News and Updates

  • Lucien Levy Best Research Article Award
  • Thanks to our 2022 Distinguished Reviewers
  • Press Releases

Resources

  • Evidence-Based Medicine Level Guide
  • How to Participate in a Tweet Chat
  • AJNR Podcast Archive
  • Ideas for Publicizing Your Research
  • Librarian Resources
  • Terms and Conditions

Opportunities

  • Share Your Art in Perspectives
  • Get Peer Review Credit from Publons
  • Moderate a Tweet Chat

American Society of Neuroradiology

  • Neurographics
  • ASNR Annual Meeting
  • Fellowship Portal
  • Position Statements

© 2023 by the American Society of Neuroradiology | Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire